Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030079
Filing Date
2019-08-07
Accepted
2019-08-07 16:16:33
Documents
54
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arav-10q_20190630.htm 10-Q 1328624
2 EX-31.1 arav-ex311_9.htm EX-31.1 17179
3 EX-31.2 arav-ex312_7.htm EX-31.2 17143
4 EX-32.1 arav-ex321_6.htm EX-32.1 7696
5 EX-32.2 arav-ex322_8.htm EX-32.2 7642
6 EX-99.1 arav-ex991_306.htm EX-99.1 44060
  Complete submission text file 0001564590-19-030079.txt   4911656

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT arav-20190630.xml EX-101.INS 963780
8 XBRL TAXONOMY EXTENSION SCHEMA arav-20190630.xsd EX-101.SCH 37960
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arav-20190630_cal.xml EX-101.CAL 39560
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20190630_def.xml EX-101.DEF 116785
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20190630_lab.xml EX-101.LAB 326683
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20190630_pre.xml EX-101.PRE 235259
Mailing Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010
Business Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 191005669
SIC: 2834 Pharmaceutical Preparations